Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results

NCT01635049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2015-01-14

No results posted yet for this study

Summary

The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva System parameters with comprehensive chromosome screening (CCS) results, implantation and live birth.

Conditions

Sponsors & Collaborators

  • Progyny, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard T Scott, Jr., MD · Reproductive Medicine Associates of New Jersey

Eligibility

Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635049 on ClinicalTrials.gov